Fresenius nears deal to acquire Akorn 0 24.04.2017 20:20 CNBC German healthcare conglomerate Fresenius is close to acquiring generic drugmaker Akorn in an all-cash deal valuing the company at more than $4 billion Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
